Drug Shortage Report for TOBRAMYCIN INJECTION USP
Report ID | 155947 |
Drug Identification Number | 02502372 |
Brand name | TOBRAMYCIN INJECTION USP |
Common or Proper name | TOBRAMYCIN FOR INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 40MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR |
Packaging size | 25 VIALS |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2021-06-21 |
Estimated end date | Unknown |
Actual end date | 2022-09-09 |
Shortage status | Resolved |
Updated date | 2022-09-10 |
Company comments | Product will be available at McKesson by end of next week. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-09-10 | English | Compare |
v5 | 2022-09-09 | French | Compare |
v4 | 2022-09-09 | English | Compare |
v3 | 2022-09-09 | English | Compare |
v2 | 2022-03-03 | French | Compare |
v1 | 2022-03-03 | English | Compare |
Showing 1 to 6 of 6